AI-powered self-service platform for all your sourcing decision needs across 1,200+ categories like Serum.
Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.Schedule a Demo
Successful Transition of Cell Line Development With Animal Origin Component Free MediaJuly 27, 2022
Pristine Biologicals Expands Production CapacityJuly 14, 2022
Thermo Fisher Expands Animal Origin Free Media Manufacturing CapacityAugust 08, 2022
Become a Beroe LiVE.Ai™ Subscriber to receive proactive alerts on SerumSchedule a Demo
Serum Market Monitoring Dashboard
Understand the correlation between costs, margins, and prices impacting your category on a real time basis on Beroe LiVE.Ai™Schedule a Demo
Serum Industry Benchmarks
The average annual savings achieved in Serum category is 20.10%
The industry average payment terms in Serum category for the current quarter is 54.3 days
Compare your category performance against peers and industry benchmarks across 20+ parameters on Beroe LiVE.Ai™
Category Strategy and Flexibility
Price per Unit Competitiveness
Minimum Order Quality
The World’s first Digital Market Analyst
The World’s first Digital Market Analyst
Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions
Abi is now supercharged with GPT4 AI engine. Enjoy the ease of ChatGPT, now on Abi
Serum Market Intelligence
global market outlook
- The global market size is 660,000 Liters in 2021 and the market is expected to grow at a CAGR of approx. 8–9 percent to 1077,000 liters by 2027
- The APAC region is leading in the supply of FBS, limited demand exists for FBS in the Asian region. Several organizations in North America have been involved in the development of COVID-19 vaccines and drugs, which has increased the demand for FBS
- Australia and New Zealand-origin serum or FBS are considered to be superior to other regions of origin. This is because of the low BSE or disease risk that these regions hold. However, the serum activity is found to be similar across all serums and other alternatives, like US-origin serum, can be considered.
- The US-origin serum is also gaining more popularity ever since its upgrade to the negligible BSE risk category by OIE. Brazil or South American origin serum is considered as a low-cost alternative for the US-origin serum. Currently, it is more prevalent in the R&D segment than in manufacturing
- Fetal bovine blood is the basic raw material used in the manufacture of Fetal Bovine Serum. The price of fetal bovine blood varies significantly due to various factors, such as herd rebuilding, drought, etc. This is the major cost component in the manufacturing of Fetal Bovine Serum
Serum market frequently asked questions
The worldwide serum supply in 2020 was around 704,000 L. As per Beroe’s category intelligence report, the global serum market will grow at 4-5% CAGR over the next five years, reaching nearly 899,000 L total volume.
Rapid growth in the biopharmaceutical industry has been the primary driver for the global serum market. The fetal bovine serum (FBS) has been supplementing cell culture media for several decades. Furthermore, increasing demand from emerging regions, such as South Korea and other developing nations, will likely offer another leg of growth.
While the US holds a significant revenue share in the global serum market, players prefer Australia and New Zealand for sourcing FBS owing to the lowest risk of transmissible spongiform encephalopathy (TSE) and bovine spongiform encephalopathy (BSE).
Specific ethical, scientific, and supply challenges have compelled researchers to look for a substitute for FBS. Moreover, the supply of FBS is limited and is subject to various factors including, cattle cycles, beef demand, and weather patterns. Furthermore, issues with the supply chain monitoring of FBS are impacting manufacturers’ bottom lines.
While there is a shift towards artificial serum, animal-based serums, especially FBS, find use in specific applications. Further, think tanks have dedicated several years to research in order to discover a substitute to FBS; however, they have yet to find a solid alternative.
The US, Brazil, and Australia are the major serum producers worldwide. While the North American serum market is growing at a 4-5% CAGR, the market size in Europe is expanding at around 5% CAGR.
Serum market report transcript
Global Market Outlook on Serum
Supply market for FBS is split across the US, Australia, Brazil, etc. The US contributes to the highest market share, which is greater than Australia and New Zealand
Dual sourcing of FBS is usually followed by major pharmaceutical companies for commercial manufacturing and R&D applications
Suppliers are evaluated for long-term supply assurance and traceability of serum
Usage of South American origin FBS has increased, particularly in the research community
Serum Market Overview
The volume of FBS produced globally in 2022 is estimated to be around 670,000 L. The US, Australia, New Zealand, and Brazil are some of the major regions for FBS production.
The global FBS market is projected to grow at a rate of 8–9 percent for the next few years and reach a total volume of nearly 1094,000 L by 2028
The FBS volume is increased in 2022 compared to 2021, since the slaughter rates have increased in 2022 compared to 2021
New Zealand and Australia, having the lowest risk of BSE and TSE, are the most preferred locations for sourcing FBS
Increasing demand for FBS, coupled with slow growth in raw material fetal bovine blood (FBB), is one of the key challenges in the market
Although there is a shift toward artificial serum, there are certain applications for animal-based serum (especially, FBS), which cannot be overseen
Industry Drivers and Constraints : Serum
Health status of the country of origin affects the price of FBS although the place of origin does not affect the product quality or activity.
Demand for FBS has been driven by the rapid growth in the biopharmaceutical industry. Cell culture media has been supplemented by FBS for many decades now
Demand from new regions, like South Korea and other developing countries, is expected to fuel the demand for FBS
FBS sourced from New Zealand and Australia are always preferred over any other serum, since they are free from any risk and assumed to offer better results
Due to the certain scientific, ethical and supply challenges, researchers have been forced to identify an alternative for FBS
Supply of FBB is finite and it often affected by factors, like weather pattern, dairy market, cattle cycles, and beef demand
Issues in traceability with the supply chain of FBS is a crucial factor that affects market growth
Cost Structure Analysis : Serum
Major cost component in the manufacturing of FBS is the raw material Fetal bovine blood. Its availability and origin drive the final price of FBS
Availability of the major raw material fetal bovine blood may be affected by climatic conditions, herd rebuilding, drought, etc.
Fetal bovine blood is the basic raw material used in the manufacture of FBS. The price of fetal bovine blood varies significantly due to various factors, such as herd rebuilding, drought, etc. This is the major cost component in the manufacturing of FBS
Considerable amount of labor is involved in the manufacture of FBS and also in ensuring that the serum processed is of utmost quality and meets the required standards
Quality and compliance are very crucial in the manufacturing of FBS and hence, it occupies nearly 5 percent of the total FBS manufacturing cost
Discover the world of market intelligence and how it can elevate your business strategies.
Learn more about how market intelligence can enable informed decision-making, help identify growth opportunities, manage risks, and shape your business's strategic direction.